Guidance Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Sell
873
-1,602
-65% -$443K 0.05% 226
2026
Q1
$710K Buy
2,475
+400
+19% +$119K 0.16% 136
2025
Q4
$584K Buy
2,075
+283
+16% +$76.9K 0.14% 147
2025
Q3
$483K Sell
1,792
-31
-2% -$8.44K 0.13% 158
2025
Q2
$512K Buy
1,823
+713
+64% +$194K 0.15% 138
2025
Q1
$311K Buy
+1,110
New +$274K 0.1% 178

Other funds holding CME

Guidance Capital's CME Position: Q2 2026 in Review

Guidance Capital reduced its CME Group (CME) stake by 65% in Q2 2026, selling an estimated $443K and leaving 873 shares worth $215K. The position accounts for 0.05% of the portfolio, ranked #226.

Guidance Capital first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $710K in Q1 2026. 309 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Guidance Capital held 873 shares of CME Group worth $215K as of Q2 2026.
  • Guidance Capital sold 1,602 CME Group shares in Q2 2026, an estimated $443K.
  • CME Group made up 0.05% of Guidance Capital's portfolio in Q2 2026, its #226 holding.
  • Guidance Capital first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • Guidance Capital's CME Group position peaked at $710K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Guidance Capital's 13F filing for Q2 2026, filed 20 Jul 2026.